PortfoliosLab logoPortfoliosLab logo
FRT vs. WST
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

FRT vs. WST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Federal Realty Investment Trust (FRT) and West Pharmaceutical Services, Inc. (WST). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FRT achieves a 21.00% return, which is significantly higher than WST's 13.65% return. Over the past 10 years, FRT has underperformed WST with an annualized return of 1.16%, while WST has yielded a comparatively higher 15.72% annualized return.


FRT

1D
0.47%
1M
3.47%
YTD
21.00%
6M
24.97%
1Y
30.75%
3Y*
14.25%
5Y*
4.41%
10Y*
1.16%

WST

1D
-1.31%
1M
3.82%
YTD
13.65%
6M
14.53%
1Y
49.58%
3Y*
-2.89%
5Y*
-1.01%
10Y*
15.72%
*Multi-year figures are annualized to reflect compound growth (CAGR)

FRT vs. WST - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
FRT
Federal Realty Investment Trust
21.00%-5.91%12.07%6.55%-22.66%65.97%-30.66%12.51%-8.10%-3.59%
WST
West Pharmaceutical Services, Inc.
13.65%-15.73%-6.75%49.97%-49.70%65.88%89.05%54.13%-0.08%17.02%

Correlation

The correlation between FRT and WST is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.26

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.29

Correlation (10Y)
Calculated over the trailing 10-year period

0.21

Correlation (All Time)
Calculated using the full available price history since Jan 6, 1988

0.23

Fundamentals

Market Cap

FRT:

$10.34B

WST:

$22.60B

EPS

FRT:

$5.87

WST:

$7.47

PE Ratio

FRT:

20.34

WST:

41.79

PS Ratio

FRT:

7.85

WST:

7.04

PB Ratio

FRT:

3.28

WST:

7.56

Total Revenue (TTM)

FRT:

$1.31B

WST:

$3.22B

Gross Profit (TTM)

FRT:

$703.03M

WST:

$1.17B

EBITDA (TTM)

FRT:

$1.09B

WST:

$799.00M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FRT vs. WST — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FRT
FRT Risk / Return Rank: 8585
Overall Rank
FRT Sharpe Ratio Rank: 8585
Sharpe Ratio Rank
FRT Sortino Ratio Rank: 8484
Sortino Ratio Rank
FRT Omega Ratio Rank: 8080
Omega Ratio Rank
FRT Calmar Ratio Rank: 8989
Calmar Ratio Rank
FRT Martin Ratio Rank: 8888
Martin Ratio Rank

WST
WST Risk / Return Rank: 7575
Overall Rank
WST Sharpe Ratio Rank: 7676
Sharpe Ratio Rank
WST Sortino Ratio Rank: 7979
Sortino Ratio Rank
WST Omega Ratio Rank: 7575
Omega Ratio Rank
WST Calmar Ratio Rank: 7474
Calmar Ratio Rank
WST Martin Ratio Rank: 7171
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FRT vs. WST - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Federal Realty Investment Trust (FRT) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


FRTWSTDifference

Sharpe ratio

Return per unit of total volatility

1.81

1.21

+0.60

Sortino ratio

Return per unit of downside risk

2.64

2.25

+0.39

Omega ratio

Gain probability vs. loss probability

1.31

1.27

+0.04

Calmar ratio

Return relative to maximum drawdown

4.41

1.96

+2.44

Martin ratio

Return relative to average drawdown

10.78

3.94

+6.84

FRT vs. WST - Sharpe Ratio Comparison

The current FRT Sharpe Ratio is 1.81, which is higher than the WST Sharpe Ratio of 1.21. The chart below compares the historical Sharpe Ratios of FRT and WST, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


FRTWSTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.81

1.21

+0.60

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.19

-0.03

+0.22

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.04

0.46

-0.42

Sharpe Ratio (All Time)

Calculated using the full available price history

0.41

0.39

+0.02

Drawdowns

FRT vs. WST - Drawdown Comparison

The maximum FRT drawdown since its inception was -57.42%, roughly equal to the maximum WST drawdown of -59.29%. Use the drawdown chart below to compare losses from any high point for FRT and WST.


Loading charts...

Drawdown Indicators


FRTWSTDifference

Max Drawdown

Largest peak-to-trough decline

-57.42%

-59.29%

+1.87%

Max Drawdown (1Y)

Largest decline over 1 year

-6.96%

-24.70%

+17.74%

Max Drawdown (3Y)

Largest decline over 3 years

-27.38%

-53.79%

+26.41%

Max Drawdown (5Y)

Largest decline over 5 years

-34.99%

-59.29%

+24.30%

Max Drawdown (10Y)

Largest decline over 10 years

-56.47%

-59.29%

+2.82%

Current Drawdown

Current decline from peak

-1.44%

-32.97%

+31.53%

Average Drawdown

Average peak-to-trough decline

-11.78%

-16.88%

+5.10%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.85%

12.32%

-9.47%

Volatility

FRT vs. WST - Volatility Comparison

The current volatility for Federal Realty Investment Trust (FRT) is 4.22%, while West Pharmaceutical Services, Inc. (WST) has a volatility of 8.65%. This indicates that FRT experiences smaller price fluctuations and is considered to be less risky than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FRTWSTDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.22%

8.65%

-4.43%

Volatility (6M)

Calculated over the trailing 6-month period

11.78%

25.52%

-13.74%

Volatility (1Y)

Calculated over the trailing 1-year period

17.10%

41.28%

-24.18%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.35%

40.56%

-17.21%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

29.44%

34.63%

-5.19%

Dividends

FRT vs. WST - Dividend Comparison

FRT's dividend yield for the trailing twelve months is around 3.76%, more than WST's 0.28% yield.


PositionTTM20252024202320222021202020192018201720162015
FRT
Federal Realty Investment Trust
3.76%4.39%2.93%4.21%4.26%3.12%4.96%3.22%3.42%2.98%2.70%2.48%
WST
West Pharmaceutical Services, Inc.
0.28%0.31%0.25%0.22%0.31%0.15%0.23%0.41%0.58%0.54%0.58%0.75%

Financials

FRT vs. WST - Financials Comparison

This section allows you to compare key financial metrics between Federal Realty Investment Trust and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


200.00M300.00M400.00M500.00M600.00M700.00M800.00M20222023202420252026
341.08M
844.90M
(FRT) Total Revenue
(WST) Total Revenue
Values in USD except per share items

FRT vs. WST - Profitability Comparison

The chart below illustrates the profitability comparison between Federal Realty Investment Trust and West Pharmaceutical Services, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

10.0%20.0%30.0%40.0%50.0%60.0%70.0%20222023202420252026
70.9%
35.1%
Portfolio components
FRT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Federal Realty Investment Trust reported a gross profit of 241.87M and revenue of 341.08M. Therefore, the gross margin over that period was 70.9%.

WST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, West Pharmaceutical Services, Inc. reported a gross profit of 296.40M and revenue of 844.90M. Therefore, the gross margin over that period was 35.1%.

FRT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Federal Realty Investment Trust reported an operating income of 116.27M and revenue of 341.08M, resulting in an operating margin of 34.1%.

WST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, West Pharmaceutical Services, Inc. reported an operating income of 177.10M and revenue of 844.90M, resulting in an operating margin of 21.0%.

FRT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Federal Realty Investment Trust reported a net income of 159.10M and revenue of 341.08M, resulting in a net margin of 46.7%.

WST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, West Pharmaceutical Services, Inc. reported a net income of 138.80M and revenue of 844.90M, resulting in a net margin of 16.4%.


Frequently Asked Questions


FRT and WST have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

WST has higher volatility (8.65%) compared to FRT (4.22%). In terms of maximum drawdown, FRT dropped -57.42% vs WST's -59.29%.

FRT currently has the higher Sharpe Ratio (1.81 vs 1.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FRT and WST

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer